Table 4 Indications of specific treatment
CharacteristicAll patients (n = 200)Patients with PRSS1 mutations (n = 135)Patients without detected PRSS1 mutation (n = 65†)p Value
Chronic use of analgesics (%)* (md = 2)20 (10)146NS
Endoscopic treatment (%) (md = 3)31 (16)247NS
Surgical treatment (%) (md = 1)49 (24)3910NS
  • *At least one period of chronic use >3 months.

  • †Including nine patients deceased before 1996, in whom PRSS1 mutation could not be searched for.

  • md, Missing data; NS, not significant; PRSS1, cationic trypsinogen gene.